News
Abbott Laboratories (NYSE:ABT) is one of the defensive stocks that billionaires are buying amid US trade tariff uncertainty.
StockStory.org on MSN13d
Why Abbott Laboratories (ABT) Shares Are Plunging Today
What Happened? Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.1% in the afternoon session after the company reported second-quarter earnings that beat analyst ...
It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, when its stock has declined 5.8% over the past month. However, a closer look at its sound financials ...
Abbott Laboratories (NYSE:ABT) ranks among the best low volatility stocks to buy according to analysts. RBC Capital ...
Abbott forecasts an adjusted operating margin of approximately 23.5% of sales, down from prior guidance of 23.5%- 24.0%.
Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig.
Shares of ABT stock opened at $131.00 on Thursday. The company has a quick ratio of 1.14, a current ratio of 1.60 and a debt-to-equity ratio of 0.32. Abbott Laboratories has a 52 week low of $99. ...
Conversely, if the dividend payment decreases, so will the yield. ABT Price Action: Shares of Abbott Laboratories gained 0.9% to close at $127.96 on Monday. Read More: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results